Express Scripts (ESRX): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

Express Scripts ( ESRX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.9%. By the end of trading, Express Scripts rose $1.18 (1.9%) to $62.49 on heavy volume. Throughout the day, 8,185,824 shares of Express Scripts exchanged hands as compared to its average daily volume of 5,376,900 shares. The stock ranged in a price between $61.10-$63.38 after having opened the day at $61.47 as compared to the previous trading day's close of $61.31. Other companies within the Health Services industry that increased today were: TranS1 ( TSON), up 13.2%, Kindred Healthcare ( KND), up 9.1%, Electromed ( ELMD), up 7.3% and Kips Bay Medical ( KIPS), up 7.0%.
  • EXCLUSIVE OFFER: Jim Cramer's Protege, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $50.1 billion and is part of the health care sector. The company has a P/E ratio of 36.3, above the S&P 500 P/E ratio of 17.7. Shares are up 13.6% year to date as of the close of trading on Tuesday. Currently there are 13 analysts that rate Express Scripts a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the negative front, Escalon Medical Corporation ( ESMC), down 15.3%, Lakeland Industries ( LAKE), down 14.3%, Natus Medical ( BABY), down 7.0% and Retractable Technologies ( RVP), down 6.3% , were all laggards within the health services industry with Thermo Fisher Scientific ( TMO) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

null

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers